Уважаемые коллеги, доброго времени суток! Представляем вам швейцарское научное издание Ocular Oncology and Pathology. Журнал имеет второй квартиль, издаётся в S. Karger AG, его SJR за 2022 г. равен 0,36, импакт-фактор 1,0, печатный ISSN - 2296-4681, электронный - 2296-4657, предметная область Уход за больными. Вот так выглядит обложка:
Здесь два редактора - Арун Сингх, контактные данные - singha@ccf.org
и Ханс Гроссниклаус - ophtheg@emory.edu.
Журнал содержит подборку актуальных клинических и фундаментальных исследовательских статей, охватывающих этиологию, патологию, методы диагностики, особенности визуализации и достижения в медицинском и хирургическом лечении рака глаз. Основное внимание уделяется клинико-патологическим корреляциям, клиническим исследованиям, основанным на фактических данных, и трансляционной науке. В дополнение к оригинальным статьям, журнал публикует своевременные обзоры, спорные темы и резюме соответствующих статей, чтобы гарантировать, что его читатели будут хорошо информированы.
Адрес издания - https://karger.com/OOP
Пример статьи, название - Can Enhancement Pattern in Normal-Sized Optic Nerves on Magnetic Resonance Imaging Better Predict Tumor Invasion in Retinoblastoma Eyes? Заголовок (Abstract)
Introduction: Optic nerve (ON) enhancement alone without ON thickening on contrast-enhanced magnetic resonance imaging (CE-MRI) can be associated with post-laminar optic nerve invasion (PLONI) in eyes with group E retinoblastoma. A few case reports and retrospective studies in the literature show a poor correlation between ON enhancement on MRI and ON invasion on histopathological examination (HPE). There is no universal consensus on the management of such cases. It is desirable that the presence and extent of a true ON invasion be reliably picked up before planning upfront enucleation in order to avoid stage II disease. Methods: In a prospective study conducted at a tertiary eye care center in North India, all retinoblastoma patients presenting with ON enhancement on imaging were evaluated. Demographic and imaging details, histopathological findings, and treatment details were recorded. The length and pattern of enhancement noted on MRI were correlated with histopathology. Follow-up was done till the end of the study period. Results: Six group E retinoblastoma eyes were evaluated. 3 eyes (50%) showed solid enhancement, 2 eyes (33.33%) had tram track pattern and 1 eye (16.66%) showed punctate enhancement pattern on CE-MRI. On histopathology, 5 (83.33%) cases showed PLONI and all 6 (100%) had ON head infiltration. The cut end of the ON was free in all cases. On correlating MRI and HPE, all eyes with solid enhancement pattern showed PLONI, of which 2/3 (66.6%) had diffuse ON infiltration. Only 50% of eyes with tram track patterns showed PLONI. The case which showed a punctate enhancement pattern showed focal infiltration by tumor cells with vacuolated cytoplasm on HPE. At the last follow-up, all patients were alive and free of disease. Conclusion: ON enhancement patterns may make it more predictive for PLONI on HPE. Solid enhancement pattern appears to correlate better with the extent of ON invasion on HPE, and longer lengths of solid ON enhancement may be considered for neoadjuvant chemotherapy rather than upfront enucleation.
Keywords: Extraocular retinoblastoma, Optic nerve enhancement, Ocular oncology, Ocular pathology, Ocular radiology